The first pill that can slow the progression of multiple sclerosis goes on the market next month. It won't be cheap, though. Analysts figure it will cost around $30,000 a year.
Read More...
Read the complete post at http://www.npr.org/blogs/health/2010/09/22/130046931/novartis-pill-for-multiple-sclerosis-wins-approval-but-at-what-cost?ft=1&f=103537970
Posted
Sep 22 2010, 10:24 AM
by
NPR Blogs: Shots - Health News Blog